Physical Activity across Frailty Phenotypes in Females with Parkinson’s Disease

Table 1

Participant characteristics across frailty phenotypes in PD and non-PD females.

	PD			Non-PD
	Nonfrail	Prefrail	Frail	Nonfrail	Prefrail	Frail
𝑁	4	7	4	8	4	3
Age	69 ± 1	65 ± 10	63 ± 11	63 ± 8^ab	79 ± 14^b	90 ± 6
Body mass index (kg/m^2)	26.31 ± 5.6	22.95 ± 4.3	25.06 ± 4.3	23.20 ± 5.7	34.60 ± 5.4	32.49 ± 12.2
Number of medications	4.0 ± 2.0	2.9 ± 1.5	3.3 ± 2.6	1.3 ± 1.3	6.0 ± 4.2	5.3 ± 0.6
mg carbidopa-levodopa per day	366.67 ± 57.7	571.43 ± 340.2	825.00 ± 330.4
carbidopa-levodopa only (𝑁)	2	3	2
carbidopa-levodopa + pram (𝑁)	2	2	0
carbidopa-levodopa + enta (𝑁)	0	0	1
carbidopa-levodopa + enta + pram (𝑁)	0	1	1
carbidopa-levodopa + aman + rop (𝑁)	0	1	0
Hoehn & Yahr disease severity	1.83 ± 0.8	1.86 ± 0.6	2.50 ± 0.4

PD: Parkinson’s disease, 𝑁: number, kg: kilogram, m: meter, mg: milligram, pram: pramipexole, enta: entacapone, aman, amantadine, and rop: ropinirole.
^aSignificantly different from prefrail.
^bSignificantly different from frail.